DOI: 10.1212/WNL.0000000000004825
,
,
PMID: 29335307
Issn Print: 0028-3878
Publication Date: 2018/01/16
Editors' note: A phase 3 trial of IV immunoglobulin for Alzheimer disease
Chafic Karam; Robert C. Griggs
Checking for direct PDF access through Ovid |
Abstract
Abstract unavailable for this article.